NCT03440645

Brief Summary

Over a 12-month period, patients admitted with acute coronary disease to the cardiovascular care unit at the Jewish General Hospital (JGH), an academic tertiary care referral center in Montreal, Quebec, will be approached to refer first-degree relatives and/or household members age 18 years or older to an outpatient cardiovascular (CV) risk factor screening and treatment program. Relatives and household members will undergo a focused history, physical, and CV risk factor assessment and will receive evidence-based guideline-recommended treatment as indicated. Participants will be referred to nutritionists, smoking cessation programs, and to other allied healthcare professionals as needed. A follow-up visit at 6-months will assess treatment adherence and improvement in CV risk factors. All family and/or household members including the index patient will be encouraged to attend all healthcare visits together. The effectiveness of the screening strategy will be measured by the total number of participants identified as intermediate or high modified Framingham 10-year risk of cardiovascular disease. The effectiveness of the primary prevention intervention will be measured by the change in percentage of the mean modified Framingham 10-year risk score for participants between the initial visit and 6-month follow-up. The value of the referral, screening, and treatment program, as well as participant engagement and satisfaction will also be systematically evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

January 9, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2020

Completed
Last Updated

October 14, 2020

Status Verified

October 1, 2020

Enrollment Period

2.4 years

First QC Date

January 4, 2018

Last Update Submit

October 13, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mean modified Framingham cardiovascular risk score from the initial visit to the 6 month follow-up visit

    The change in percentage of the mean modified Framingham cardiovascular risk score for family and household members between the initial visit and the 6-month follow-up visit

    6 months

Secondary Outcomes (1)

  • Effectiveness of the screening strategy

    12 months of study recruitment

Study Arms (1)

Family or Household Members

EXPERIMENTAL
Other: Family-oriented primary cardiovascular prevention

Interventions

An initial screening visit including a targeted history, physical exam, and investigations as per the Canadian Cardiovascular Society's recommendations for cardiovascular primary prevention. Counselling and informational handouts on improved cardiovascular risk factor and lifestyle habits. All family and household members, as well as the cardiovascular disease proband, are encouraged to attend and participate in all healthcare visits.

Family or Household Members

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age ≤70 years old admitted with an initial diagnosis of an acute coronary event (such as acute coronary syndrome or myocardial infarction)
  • At least 1 first-degree family or household member age ≥ 18 years old

You may not qualify if:

  • No eligible family or household members
  • Inability to contact family or household members
  • Distance to study centre too far as determined by the patient
  • Family or household members who have been screened for CV disease in the previous 2 years.
  • Family or household members with known coronary disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital / Lady Davis Institute

Montreal, Quebec, H3T 1E2, Canada

Location

Study Officials

  • Michael Goldfarb, MD

    Lady Davis Institute for Medical Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician-Investigator

Study Record Dates

First Submitted

January 4, 2018

First Posted

February 22, 2018

Study Start

January 9, 2018

Primary Completion

May 30, 2020

Study Completion

May 30, 2020

Last Updated

October 14, 2020

Record last verified: 2020-10

Locations